WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015

Nov 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-11-10

Reporting Person: Flynn Karen (President, Pharma Pckg Systems)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-10	Common Stock	M	9458.0000	$21.3400	Acquired	34067.8300	Direct
2015-11-10	Common Stock	M	8562.0000	$20.4250	Acquired	42629.8300	Direct
2015-11-10	Common Stock	S	18020.0000	$63.0257	Disposed	24609.8300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-10	Stock Option (Right to Buy)	$20.4250	M	8562.0000	Disposed	2021-02-22	Common Stock (8562.0000)	Direct
2015-11-10	Stock Option (Right to Buy)	$21.3400	M	9458.0000	Disposed	2020-03-22	Common Stock (9458.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	311.7300	Indirect
Common Stock	1070.0720	Indirect

Footnotes

F1: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $63.01 to $63.155, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.